EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CPT1A Alleviates Senescence and Restores Osteogenic Differentiation of BM ‐ MSC Through SOD2 Succinylation

Xiao Yuan Wang, Shi Chang Liu, Xu Xu Chen, Liang Yan, Liang Li, Gao Le He, Ming Yang, Zhong Kai Liu iD, Xin Hua Yin iD

Journal of Cellular and Molecular Medicine · 2025-03 · 29 (5)

DOI: 10.1111/jcmm.70473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 11.03.2025. Verfasst von Xiao Yuan Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Physical Examination Center, Xi'an International Medical Center Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Osteogenesis, Superoxide Dismutase, Cellular Senescence, Mesenchymal Stem Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Youth Science Fund Project of Xi'an International Medical Center Hospital, Social Development Science Foundation of the Department of Science and Technology of ShanXi province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone marrow mesenchymal stem cells (BM‐MSCs) have promising prospects in bone repair and regenerative medicine. However, BM‐MSCs gradually lose their original pluripotency and differentiation potential after successive passages. This study aimed to reveal the mechanism underlying the phenomenon. Western blotting, SA‐β‐gal staining and Alizarin red staining were used to evaluate the senescence phenotype and osteogenic differentiation ability. Mitochondrial ROS levels were detected using flow cytometry. Protein interactions and succinylation modifications were identified by using Co‐IP assays. With the increase in passage times, the proliferation and osteogenic differentiation of BM‐MSCs were gradually weakened, and the expression level of CPT1A was decreased. BM‐MSCs with fewer passages (P1–P5 generations) showed increased mitochondrial ROS production and reduced enzyme activity of superoxide dismutase 2 (SOD2) and the mitochondrial level after the knockdown of CPT1A. In contrast, overexpression of CPT1A in multiple‐round‐passed BM‐MSCs cells (P10–P15 generations) has the opposite effect. Therefore, CPT1A level is associated with the ageing phenotypes and the osteogenic differentiation capacity of BM‐MSCs. Knocking down CPT1A significantly reduced the succinylation modification of SOD2, resulting in a decrease in SOD2 enzyme activity and SOD2 levels in mitochondria. Overexpression of CPT1A enhanced the succinylation of SOD2 at the key site K130, thereby reducing cell senescence and promoting osteogenic differentiation. However, this boosting effect was reversed when a mutation occurred at the K130 site of SOD2. CPT1A promotes succinylation modification at the SOD2 (K130) site to induce the accumulation of SOD2 in mitochondria and the enzyme activity, which alleviates BM‐MSC senescence and enhances osteogenic differentiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisSuperoxide DismutaseCellular SenescenceMesenchymal Stem CellsCell DifferentiationCarnitine O-PalmitoyltransferaseBone Marrow CellsMitochondriaReactive Oxygen SpeciesHumansCell ProliferationCells, CulturedAnimalsSuperoxide Dismutase 2

Stichwörter der Autor:innen

BM‐MSCCPT1ASOD2osteogenic differentiationsuccinylation

Substanzen

Superoxide DismutaseCarnitine O-PalmitoyltransferaseReactive Oxygen SpeciesSuperoxide Dismutase 2

Autor:innen und Institutionen

  • Physical Examination Center, Xi'an International Medical Center Hospital, Xi'an, China.
  • Department of Spine Surgery, Hong Hui Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, China.
  • Department of Sports Medicine, Hong Hui Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, China.

ORCID-Profile: Zhong Kai Liu, Xin Hua Yin

Förderung

  • Youth Science Fund Project of Xi'an International Medical Center Hospital
  • Social Development Science Foundation of the Department of Science and Technology of ShanXi province

Zitieren

APA

Wang, X. Y., Liu, S. C., Chen, X. X., Yan, L., Li, L., Le He, G., Yang, M., Liu, Z. K., & Yin, X. H. (2025). CPT1A Alleviates Senescence and Restores Osteogenic Differentiation of BM ‐ MSC Through SOD2 Succinylation. Journal of Cellular and Molecular Medicine, 29(5). https://doi.org/10.1111/jcmm.70473

Vancouver

Wang XY, Liu SC, Chen XX, Yan L, Li L, Le He G, et al. CPT1A Alleviates Senescence and Restores Osteogenic Differentiation of BM ‐ MSC Through SOD2 Succinylation. Journal of Cellular and Molecular Medicine. 2025;29(5). doi:10.1111/jcmm.70473

BibTeX
@article{Wang2025,
  author = {Wang, Xiao Yuan and Liu, Shi Chang and Chen, Xu Xu and Yan, Liang and Li, Liang and Le He, Gao and Yang, Ming and Liu, Zhong Kai and Yin, Xin Hua},
  title = {CPT1A Alleviates Senescence and Restores Osteogenic Differentiation of BM ‐ MSC Through SOD2 Succinylation},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  volume = {29},
  number = {5},
  doi = {10.1111/jcmm.70473}
}
Kostenlos starten →